The lipid composition of human testis in testicular and post-testicular causes of infertility was studied. The testicular causes of infertility was represented by patients with adult seminiferous tubule failure and Klinefelter’s syndrome. The post-testicular causes of infertility were represented by patients with obstruction of efferent ducts of testes. A significant accumulation of total testicular lipids was observed in both causes of infertility. A marked increase in free and esterified cholesterol, monoglycerides and triglycerides caused the accumulation of total testicular lipids in testicular causes of infertility. The accumulation of these lipids was more pronounced in Klinefelter’s syndrome compared to adult seminiferous tubule failure. In post-testicular causes of infertility, a very marked increase in phospholipids along with cholesterol fractions and glycerides led to the accumulation of total testicular lipids. The significant increase in total phospholipids caused by the increases in phosphatidylcholine and phosphatidylethanolamine differentiates post-testicular causes of infertility from testicular causes in which phospholipid classes remained unaffected. Thus, changes in hormonal mileu due to pathological conditions also lead to marked alterations in testicular lipids.

Keywords:
Lipids, Phospholipids, Male infertility, Testicular biopsy, Testicular causes, Post-testicular causes
This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.